AveXis, Inc.
Entity

  • AveXis, Inc.

    Created in 2010
  • BETA

    Probably non active (C)
    Several signals show that this company is not active anymore

  • Social networks

    1,925 32,505

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    2275 Half Day Rd Ste 200, Deerfield, IL 60015, USA

    Deerfield

    United States of America

  • Employees

    Scale: 1001-5000

    Estimated: 107

  • Engaged corporates

    1
    0 0

  • Added in Motherbase

    4 years, 10 months ago
Description
  • Value proposition

    AveXis is now Novartis Gene Therapies

    Novartis Gene Therapies (formerly AveXis) is reimagining medicine to transform the lives of people living with rare genetic diseases. Utilizing cutting-edge technology, we are working to turn promising gene therapies into proven treatments, beginning with our transformative gene therapy for spinal muscular atrophy (SMA).

    Follow us on LinkedIn: https://www.linkedin.com/company/novartis-gene-therapies/

    How to reach us:
    Novartis Gene Therapies
    2275 Half Day Road, Suite 200 Bannockburn, IL 60015
    Email: gtx.communications@novartis.com
    Office Phone: 847.572.8280
    Toll-free Phone: 844.428.3947

    Gene Therapy, Synthetic Biology, and Spinal Muscular Atrophy

Corporate interactions BETA
Corporate TypeTweets Articles
Biogen
Biogen
Biotechnology, Biotechnology Research
Biogen
Biotechnology, Biotechnology Research 		Other

2 Apr 2019


Similar entities
Last news
Show all articles
Social network dynamics